Literature DB >> 10331105

Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: a pilot study.

R Warner1, J Laugharne, M Peet, L Brown, N Rogers.   

Abstract

BACKGROUND: There is a growing body of evidence that abnormalities of the cell membrane, particularly depletion of n-3 essential fatty acids (EFA), are found in patients suffering from schizophrenia. These fatty acids particularly Docosohexaenoic acid (DHA) are found in particularly high concentrations in the photoreceptor cells of the retina and abnormalities of light sensitivity have been reported in patients with schizophrenia. Animal studies have demonstrated that reduced EFA levels are associated with changes in the electrophysiological response of the retina to light as measured by the electroretinogram (ERG).
METHODS: We measured the ERG of 9 patients with schizophrenia and 9 age and sex matched control subjects. All but one of the patients was medicated.
RESULTS: Schizophrenic subjects had significantly reduced a-wave amplitudes on the ERG when compared with control subjects and the a-wave amplitude was independent of the dose of antipsychotic agents being taken. The a-wave of the ERG is thought to reflect activity of the photoreceptor cells.
CONCLUSIONS: These findings support the hypothesis that patients with schizophrenia have abnormalities of photoreceptor function, which may be a result of reduced levels of n-3 EFA in the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331105     DOI: 10.1016/s0006-3223(98)00379-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  Full-field electroretinogram in autism spectrum disorder.

Authors:  Paul A Constable; Sebastian B Gaigg; Dermot M Bowler; Herbert Jägle; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2016-02-11       Impact factor: 2.379

Review 3.  Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen; Susan J van Rensburg
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Retinal Changes in Schizophrenia: A Systematic Review and Meta-analysis Based on Individual Participant Data.

Authors:  Charalampos T Kazakos; Vasilios Karageorgiou
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

Review 5.  THE USE OF ELECTRORETINOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY IN PATIENTS WITH SCHIZOPHRENIA.

Authors:  Din Duraković; Ante Silić; Vjekoslav Peitl; Rašeljka Tadić; Kristina Lončarić; Trpimir Glavina; Daniela Šago; Ljiljana Pačić Turk; Dalibor Karlović
Journal:  Acta Clin Croat       Date:  2020-12       Impact factor: 0.932

6.  Electroretinographic Abnormalities and Sex Differences Detected with Mesopic Adaptation in a Mouse Model of Schizophrenia: A and B Wave Analysis.

Authors:  Nathalia Torres Jimenez; Justin W Lines; Rachel B Kueppers; Paulo Kofuji; Henry Wei; Amy Rankila; Joseph T Coyle; Robert F Miller; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

7.  Structural and functional retinal alterations in patients with paranoid schizophrenia.

Authors:  Ludger Tebartz van Elst; Kathrin Nickel; Evelyn B N Friedel; Hannah-Tabea Hahn; Simon Maier; Sebastian Küchlin; Michael Reich; Kimon Runge; Michael Bach; Sven P Heinrich; Jürgen Kornmeier; Dominique Endres; Dieter Ebert; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2022-09-23       Impact factor: 7.989

8.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06

9.  Commentary: Anatomical constitution of sense organs as a marker of mental disorders.

Authors:  Thomas Schwitzer; Raymund Schwan; Florent Bernardin; Coline Jeantet; Karine Angioi-Duprez; Vincent Laprevote
Journal:  Front Behav Neurosci       Date:  2016-03-24       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.